FDA New Checklist for Paxlovid

The FDA released a new checklist to help clinicians determine which patients are eligible for Paxlovid, an oral antiviral for mild to moderate COVID-19 in adults and some pediatric patients who are at high risk for severe COVID-19. The agency also updated a Paxlovid fact sheet with more specific recommendations.